ailanthone has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailly, C | 1 |
| Gong, C; Li, S; Ni, Z; Wang, L; Xu, Z; Yao, C; Zhu, S; Zhu, X; Zou, C | 1 |
1 review(s) available for ailanthone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Anticancer properties and mechanism of action of the quassinoid ailanthone.
Topics: Ailanthus; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Prostatic Neoplasms, Castration-Resistant; Quassins | 2020 |
1 other study(ies) available for ailanthone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; DNA Replication; Down-Regulation; Humans; Lung Neoplasms; Male; Mice; Quassins; Replication Protein A; Xenograft Model Antitumor Assays | 2017 |